A Concise Review of Coenzyme Q10 Supplementation in The Preventative Treatment of Migraine
Abstract
Migraine is a complex and heterogeneous syndrome that lacks clearly defined treatment. An effective prophylactic therapy with minimal side effect profile is of interest to patients and clinicians alike. CoEnzyme Q10, a critical member of the electron transport chain, has been proposed to play a role in the pathogenesis of migraine in certain patients. In this article, we provide a concise review of the proposed physiology of coEnzyme Q10 supplementation and its role in prophylaxis against pediatric and adult migraine. Robust data on this subject is lacking, though early evidence supports its routine use in clinical practice
Read the paper
Related studies
- Bioactive Molecules Released in Food by Lactic Acid Bacteria: Encrypted Peptides and Biogenic Amines
- A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications
- Bioaccessibility and bioavailability of phenolic compounds
- The Glutamate Hypothesis in ALS: Pathophysiology and Drug Development
- Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery
- Effects of the Mediterranean Diet on the Components of Metabolic Syndrome Concerning the Cardiometabolic Risk
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.